Nexus Surgical and Medicare Ltd (NEXUSSURGL) is currently trading at 20.39 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Nexus Surgical and Medicare Limited is a Mumbai-headquartered wholesale trader of medical essentials, primarily dealing in disposable syringes (with and without needles) and sterilization pouches; the company was incorporated in 1992 and repositioned to medical consumables in 2020 under the Nexus Surgical and Medicare name, pursuing a one-stop solution strategy for hospital supplies. Q1 FY2027 sales were Rs. 254.80 lakhs, up materially from Rs. 172.52 lakhs in Q1 FY2026, representing strong year-on-year revenue growth close to 48%; sequential quarterly sales also rose from Rs. 204.62 lakhs in Q4 FY2026, indicating continuing demand and improved topline traction in the trading business. Profit before tax for the quarter was Rs. 27.28 lakhs with reported profit after tax of Rs. 20.42 lakhs, delivering a quarterly PAT margin around eight percent; while the company returned to positive profitability on a trailing basis, its balance sheet shows negative other equity of Rs. (367.21) lakhs, reflecting accumulated past losses. Operating expense structure shows a large ‘Other expense’ line (Rs. 165.97 lakhs for the quarter) and significant purchases of stock-in-trade (Rs. 60.29 lakhs), underscoring working capital intensity and cost control as immediate management priorities to protect margins and cash generation in a trading-heavy model. Corporate governance and reporting: the Q1 results were audited via limited review, approved by the Board on August 13, 2026, and the company reported no investor complaints for the quarter, suggesting routine compliance and timely disclosures consistent with listed company obligations.

Over the past 52 weeks, Nexus Surgical and Medicare Ltd has traded between a low of ₹13.26 and a high of ₹35.79. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Nexus Surgical and Medicare Ltd has a market capitalization of approximately 11.16. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Nexus Surgical and Medicare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.31 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 11.16 Cr, Nexus Surgical and Medicare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Nexus Surgical and Medicare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Nexus Surgical and Medicare Ltd is 14.31. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The board approved the unaudited standalone financial results in a meeting held on 13 August 2026.